Deep Track Capital, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Oruka Therapeutics, Inc. Common stock, $0.001 Par Value (ORKA)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Oruka Therapeutics, Inc. Common stock, $0.001 Par Value
Symbol
ORKA
Shares outstanding
48,355,928 shares
Disclosed Ownership
2,161,510 shares
Ownership
4.5%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 08:50:18 UTC
Date of event
31 Dec 2025
Previous filing
13 May 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 4.5% 2,161,510 0 2,161,510 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 3.9% 1,899,455 0 1,899,455 /s/ David Kroin David Kroin, Director
David Kroin 4.5% 2,161,510 0 2,161,510 /s/ David Kroin David Kroin
Deep Track Special Opportunities Fund, LP. 0.54% 262,055 0 262,055 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP